- Home
- VIRT vs CRNX Comparison
VIRT vs CRNX Comparison
Compare VIRT & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIRT
- CRNX
- Stock Information
- Founded
- VIRT 2008
- CRNX 2008
- Country
- VIRT United States
- CRNX United States
- Employees
- VIRT N/A
- CRNX N/A
- Industry
- VIRT Investment Bankers/Brokers/Service
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- VIRT Finance
- CRNX Health Care
- Exchange
- VIRT Nasdaq
- CRNX Nasdaq
- Market Cap
- VIRT 3.3B
- CRNX 2.8B
- IPO Year
- VIRT 2015
- CRNX 2018
- Fundamental
- Price
- VIRT $43.99
- CRNX $31.75
- Analyst Decision
- VIRT Hold
- CRNX Strong Buy
- Analyst Count
- VIRT 8
- CRNX 8
- Target Price
- VIRT $37.25
- CRNX $74.86
- AVG Volume (30 Days)
- VIRT 808.3K
- CRNX 751.6K
- Earning Date
- VIRT 07-30-2025
- CRNX 08-07-2025
- Dividend Yield
- VIRT 2.18%
- CRNX N/A
- EPS Growth
- VIRT 142.03
- CRNX N/A
- EPS
- VIRT 3.46
- CRNX N/A
- Revenue
- VIRT $2,401,575,000.00
- CRNX $760,000.00
- Revenue This Year
- VIRT N/A
- CRNX $402.02
- Revenue Next Year
- VIRT N/A
- CRNX $771.03
- P/E Ratio
- VIRT $12.71
- CRNX N/A
- Revenue Growth
- VIRT 43.16
- CRNX N/A
- 52 Week Low
- VIRT $22.34
- CRNX $24.10
- 52 Week High
- VIRT $45.12
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- VIRT 57.16
- CRNX 57.94
- Support Level
- VIRT $42.53
- CRNX $28.98
- Resistance Level
- VIRT $45.12
- CRNX $32.49
- Average True Range (ATR)
- VIRT 0.98
- CRNX 1.24
- MACD
- VIRT -0.06
- CRNX 0.30
- Stochastic Oscillator
- VIRT 67.53
- CRNX 90.54
About VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages cutting edge technology to deliver liquidity to the global markets and innovative, transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.